项目 | 免疫耐受期 | 免疫清除期 | 免疫控制期 | 再活动期 | 肝硬化期 | P值 |
年龄(岁) | 37.05 ± 11.72 | 41.91 ± 12.61 | 46.37 ± 12.88 | 44.38 ± 11.62 | 50.93 ± 13.26 | 0.00 |
性别 | 29/34 | 61/43 | 22/37 | 33/33 | 62/28 | 0.00 |
PLT (×109) | 208.82 ± 57.13 | 172.19 ± 45.17 | 211.07 ± 47.42 | 179.8 ± 45.70 | 112.77 ± 51.65 | 0.00 |
ALT (U/L) | 26.9 (18~40.73) | 129 (83~299) | 21 (15~28) | 146 (71.5~245.3) | 68 (42~187) | 0.00 |
AST (U/L) | 22.55 (18.2~28.0) | 78 (46~158.25) | 18.7 (15.08~22.7) | 69 (42.3~117.3) | 59 (32.65~125.5) | 0.00 |
APRI | 0.27 (0.21~0.35) | 1.07 (0.65~2.48) | 0.24 (0.18~0.28) | 0.81 (0.45~1.73) | 1.51 (0.59~3.62) | 0.00 |
FIB-4 | 0.78 (0.51~1.19) | 1.38 (0.79~2.89) | 0.80 (0.65~1.13) | 1.39 (0.86~2.44) | 3.75 (1.61~7.76) | 0.00 |
GPR | 0.33 (0.24~0.61) | 0.38 (0.23~0.96) | 0.14 (0.08~0.19) | 0.31 (0.14~0.72) | 0.88 (0.32~1.85) | 0.00 |
RPR | 0.07 (0.05~0.17) | 0.07 (0.06~0.09) | 0.08 (0.06~0.17) | 0.07 (0.06~0.09) | 0.12 (0.09~0.21) | 0.00 |
RDW [CV (%)] | 12.6 (12.2~39) | 12.5 (12~13.18) | 13.5 (12.4~39.8) | 12.35 (11.9~13.1) | 13.1 (12.4~14.55) | 0.00 |
GGT (U/L) | 45 (14~63.5) | 45 (32~108) | 18.1 (13~25.1) | 43.5 (24.75~78) | 53.3 (34.9~91) | 0.00 |
ALB (g/l) | 44.135 (41.1~46.96) | 41.1 (38.55~44.65) | 43.69 (41.5~45.90) | 44.1 (41.33~46.45) | 38.41 (31.87~42.1) | 0.00 |